SIRT1 suppresses activating transcription factor 4 (ATF4) expression in response to proteasome inhibition

Seon Rang Woo1, Jeong-Eun Park, Yang Hyun Kim

  • 1Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, Republic of Korea.

Insights

SIRT1 (a deacetylase) suppresses activating transcription factor 4 (ATF4) protein synthesis during proteasome inhibition stress. This regulation occurs post-transcriptionally, impacting cellular stress responses.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Activating transcription factor 4 (ATF4) is a key regulator activated by cellular stress.
  • Proteasome inhibition triggers endoplasmic reticulum stress and the unfolded protein response, where ATF4 plays a crucial role.
  • Nutrient restriction, ER homeostasis, and oxidative stress activate ATF4 synthesis.

Purpose of the Study:

  • To investigate the role of SIRT1 in regulating ATF4 synthesis under stress conditions.
  • To determine the mechanism by which SIRT1 affects ATF4 levels during proteasome inhibition.

Main Methods:

  • Utilized siRNA to deplete SIRT1 in HeLa cells.
  • Employed SIRT1-overexpressing plasmids for overexpression studies.
  • Administered the proteasome inhibitor MG132.
  • Analyzed ATF4 protein and mRNA levels via Western blotting and RT-PCR.

Main Results:

  • SIRT1 depletion significantly increased ATF4 protein levels during MG132 treatment.
  • SIRT1 overexpression decreased ATF4 protein levels in the presence of MG132.
  • ATF4 mRNA levels remained unaffected by SIRT1 modulation, indicating post-transcriptional regulation.

Conclusions:

  • SIRT1 acts as a negative regulator of ATF4 protein synthesis.
  • The suppression of ATF4 by SIRT1 occurs at the post-transcriptional level.
  • SIRT1 plays a significant role in managing cellular stress responses by controlling ATF4 levels.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.6K